Results 281 to 290 of about 117,830 (339)
This cohort study of 1793 atopic dermatitis patients (aged ≥ 12) found higher infection rates with Janus kinase inhibitor treatment compared to biologic treatment, particularly for herpes infections, with a history of viral or fungal skin infection as a risk factor associated with infection.
Lian F. van der Gang+22 more
wiley +1 more source
The effects of prenatal vitamin D supplementation on respiratory and allergy-related outcomes in children: A systematic review and meta-analysis of randomized controlled trials. [PDF]
Li Q+7 more
europepmc +1 more source
Delgocitinib cream demonstrated minimal systemic exposure and no significant accumulation over time in patients with moderate to severe CHE. The systemic exposure was significantly lower versus oral administration (relative bioavailability: 0.6%). These findings suggest that no systemic pharmacological effect is expected with topical application of ...
Diamant Thaçi+5 more
wiley +1 more source
Cure for the itch: current clinical standards and therapies in allergic eczema. [PDF]
Lazor JE, Bozsoki BA, Bharadwaj P.
europepmc +1 more source
Topical JAK (Janus Kinase) Inhibitor Therapy for Chronic External Otitis in Atopic Dermatitis: A Case Report. [PDF]
Hirano K+4 more
europepmc +1 more source
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Optimal treatment for frontal fibrosing alopecia (FFA) remains contentious. An international expert panel agreed that highly/ultra‐potent topical steroids were the preferred first‐line topical therapy. Preferred systemic therapies were 5‐alpha reductase inhibitors, followed by hydroxychloroquine.
Nekma Meah+64 more
wiley +1 more source